Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Brain tumor

FORE Biotherapeutics
Regional

Fore Bio’s Plixorafenib Clears Interim Review in Brain Tumor Trial

October 4, 2025October 2, 2025 - by Timothy Alexander

PHILADELPHIA, PA — FORE Biotherapeutics announced that its investigational therapy plixorafenib has cleared an interim efficacy analysis in the Phase 2 FORTE basket study for patients with recurrent or progressive …

Fore Bio’s Plixorafenib Clears Interim Review in Brain Tumor Trial Read More

The Wistar Institute
Cancer

Wistar Researchers Uncover Key Mechanism Behind Brain Tumor Immune Suppression

March 1, 2025February 28, 2025 - by Timothy Alexander

PHILADELPHIA, PA — A groundbreaking discovery from Dr. Filippo Veglia’s lab at The Wistar Institute has revealed how aggressive brain tumors reprogram immune cells, turning them from cancer-fighters into enablers …

Wistar Researchers Uncover Key Mechanism Behind Brain Tumor Immune Suppression Read More

Trending News

  • Philadelphia Man Gets 85 Months in Armed Carjacking Case

  • Man Charged After Shotgun Fired in Graylyn Crest Neighborhood

  • 81-Year-Old Woman Wounded in Alarming Rosegate Shooting

  • Coatesville Searches Point to Persistent Housing Strain

  • Wanted Man Surrenders in Upper Chichester Assault Case

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Federal courthouse

Philadelphia Man Gets 85 Months in Armed Carjacking Case

August 20, 2026August 19, 2026

Kevin Smith

Man Charged After Shotgun Fired in Graylyn Crest Neighborhood

August 20, 2026August 19, 2026

Police News

81-Year-Old Woman Wounded in Alarming Rosegate Shooting

August 20, 2026August 19, 2026

Copyright © 2026 MyChesCo.